HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Inflammatory Bowel Disease.

Objectives To evaluate GPT-4’s performance in interpreting osteoarthritis (OA) treatment guidelines from the USA and China, ...

Bacterial breaches in immune defences and ineffective clearance exacerbate this risk, placing antimicrobial therapy at the ...

Lucknow: The microbiology department of King George's Medical University (KGMU) will investigate the effectiveness of drugs in treating viral hepatiti.

Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according t ...

The following is a summary of “Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With ...

Regular coffee consumption (2-3 cups/day) protects against liver cirrhosis, reduces fibrosis, prevents liver cancer, and ...

A Cleveland Clinic liver specialist discusses life expectancy with fatty liver disease and provides tips to take charge of your health.

NewsVoir Bangalore Karnataka [India] December 24 SOUKYA India first NABH-accredited AYUSH hospital and the visionary creation ...

The US Food and Drug Administration (FDA) has approved Sequana Medical’s alfapump for the treatment of recurrent or ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

Researchers have discovered that patients who also have biopsy-proven celiac disease (CeD) with cryptogenic cirrhosis benefit ...